FDA Grants Approval for Thalidomide ANDA213267 by NATCO
The FDA has granted approval for ANDA213267, a generic version of Thalidomide, submitted by NATCO.
Therapeutic Area
Therapeutic area intelligence for Antineoplastic with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.